Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
H-1337 Placebo
DRUG
2 trials
Sponsors
Allysta Pharmaceutical
, D. Western Therapeutics Institute, Inc.
Conditions
Glaucoma Open-Angle Primary
Glaucoma, Open-Angle
Ocular Hypertension
Phase 1
H-1337 Ophthalmic Solution Phase 1/2
Completed
NCT03452033
Allysta Pharmaceutical
Glaucoma, Open-Angle
Start: 2018-03-15
End: 2018-08-15
Updated: 2022-07-12
Phase 2
Study of Safety and Efficacy of H-1337 in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension
Completed
NCT05913232
D. Western Therapeutics Institute, Inc.
Glaucoma Open-Angle Primary, Ocular Hypertension
Start: 2023-08-28
End: 2024-08-29
Updated: 2025-08-27
Related Papers
Phase Ⅰ/Ⅱ, Double-Masked, Randomized, Vehicle-Controlled Study of H-1337 Ophthalmic Solution for Glaucoma and Ocular Hypertension.
2022-08-31
2 citations